Success Stories: A Nigerian Research Fellow in Biotechnologies Wins NIW Approval in Just 4 Months, Thanks to Our Team’s Efforts with Her Case
Client’s Testimonial:
“I am reaching out to say a big thank you for your effort and guidance toward my application.”
On February 15th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biotechnologies (Approval Notice).
General Field: Biotechnologies
Position at the Time of Case Filing: Research Fellow
Country of Origin: Nigeria
State of Residence at the Time of Filing: Minnesota
Approval Notice Date: February 15th, 2023
Processing Time: 4 months, 4 days
Case Summary:
When a client from Nigeria wanted to file her National Interest Waiver petition with our help, our team first made sure that she was aware of the requirements and then proceeded to sign the retainer agreement with her. Once these formalities were over, we began collecting her documents and found the following information in them:
- As an expert in the field of biotechnologies, her proposed research is on deciphering genomic information as well as developing and applying advanced biotechnological research. She wanted to help progress medical research and health care by pinpointing early diagnostic genetic biomarkers or pathobionts that are significant factors in disease development. This would assist in developing preventative treatments that intervene before the materialization and progression of the disease.
- Her research endeavor is of great importance because it addresses the biomolecular roots of certain medical issues and offers practical applications to reduce them on a global scale. For instance, she has investigated the major difference observed between rates of PTB among women from different areas of the world.
- Her work also has broad implications for the United States since her endeavor to decipher genomic information and develop methods to progress PTB research and healthcare involves providing the scientific community with novel information about the interrelationship of PTB, hormone concentration, and vaginal microbiome composition, which is practicable in terms of treating PTB and reducing its burden in the United States.
- Due to its clear national importance, her research has in fact been supported with funding from the U.S. Department of Agriculture (USDA), National Science Foundation (NSF), National Institute of Health (NIH), and National Center for Advancing Translational Science (NCATS).
- In the 4 years of her research, she has completed at least 10 reviews and her work has been published in 7 peer-reviewed journal articles (4 of them first-authored) which have been cited a total of 24 times according to Google Scholar.
- Not only this but her work’s value has also been identified by other experts in the field, 4 of whom sent letters recommending her work. One of them wrote:
So, when the filing was complete we waited patiently for the results. Our efforts were soon answered when we got the approval without an RFE in just 4 months and 4 days. We are very proud of this success and our firm wishes the client an amazing future ahead.